FDA clears eGenesis’ genetically engineered porcine liver for Phase I trial
eGenesis has gained US Food and Drug Administration (FDA) clearance on an investigational new drug (IND) application for a genetically…
All articles by Ross Law
Ross Law
-
-
“Resign or be fired” – APHA executive director calls out RFK Jr
American Public Health Association (APHA) executive director Dr Georges C. Benjamin has called for Robert F Kennedy, Jr (RFK Jr)…
-
MiraDx test for radiation therapy toxicity validated in new study
A new study has confirmed that a molecular diagnostic test developed by MiraDx can predict the side effects of radiation…
-
RFK Jr swings axe at US health agencies
Since Trump's return as president, the Elon Musk-helmed Department of Government Efficiency (DOGE) has been making cuts to US Government…
-
Abbott’s brain stimulation trial for depression kicks off at Mount Sinai
New York City’s Mount Sinai has become the first hospital in the US to perform a deep brain stimulation (DBS)…
-
Sinaptica begins Phase II dual neurostimulation Alzheimer’s study enrolment
Sinaptica Therapeutics has begun enrolling patients in a Phase II trial of its second-generation neuromodulation technology for treating early Alzheimer’s…
-
OCT Medical Devices 2025: AI’s value appreciable, yet human touch remains key
This year’s Outsourcing in Clinical Trials (OCT): Medical Devices conference, held in Munich, Germany on 28-29 January, was filled with…
-
OCT Medical Devices 2025: biggest regulatory requirement issues ‘start at the site level’
The challenges in meeting regulatory requirements during a clinical investigation often start at the site level, and strong communication and…
-
OCT Medical Devices 2025: patient shifts and tech driving healthcare innovation
Shifting patient demographics and the rise of AI-based technology and wearables are emerging as key drivers of innovation in the…
-
OCT Medical Devices 2025: European AI Act compliance ‘not a cause for panic’
For healthcare firms involved in the spaces of software-as-a-medical-device (SaMD), or digital devices and artificial intelligence (AI) devices, compliance with…
